November 9, 2017 — 4C Medical Technologies Inc. announced that its medical device for mitral regurgitation (MR) was presented at the Shark Tank Innovation Competition at the Transcatheter Cardiovascular Therapeutics (TCT) meeting, held Oct. 29-Nov. 2, 2017 in Denver. The device was one of the eight innovations selected among nearly fifty submissions.
4C Medical is developing the first MR treatment that preserves the native mitral valve and left ventricle using a supra-annular, atrial-only fixation technology. The novel design eliminates issues associated with current transcatheter mitral valve replacement (TMVR) technologies – which rely on placement and fixation in the native mitral annulus and left ventricle – such as obstruction of the left ventricular outflow tract, impaired function of the left ventricle and device embolization.
Philippe Généreux, M.D., presented "A Novel Transcatheter Mitral Valve Replacement Technology (4C)," in which he explained how the design and supra-annular placement of the 4C valve may extend TMVR therapy to patients who would be ineligible for alternative TMVR procedures based on the irregular anatomy of their mitral annulus or left ventricle or presence of severe calcification. Généreux is co-director of the Structural Heart Program at the Gagnon Cardiovascular Institute of Morristown Medical Center (Morristown, N.J.) and a practicing interventional cardiologist at Hôpital du Sacré-Coeur de Montréal (Montreal, Canada).
"One aspect that excites me most about the 4C valve is that it is the only scalable technology that will provide treatment options for a broad MR patient population," said Généreux. "Because the device is placed and anchored entirely in the left atrium, it does not rely on or interact with the dynamic and irregular anatomy of the mitral annulus and left ventricle. Additionally, the 4C valve may be delivered transapically or transseptally, which gives options to operators. No other valve in development today can offer the same advantages. 4C Medical's technology will answer a real unmet clinical need."
Watch the VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch at TCT 2017 — with Juan Granada, M.D.
For more information: www.4cmed.com
December 20, 2023 
